Wen Wen

Wen Wen is the founder and CEO of Huanyi Bio (焕一生物), a Chinese biotech company applying AI and systems immunology to drug discovery. Per a 2022 piece by 5Y Capital, she established the firm as the first in China to combine AA algorithms with systems immunology data, building a multi-omics computational platform focused on oncology, autoimmune diseases, and neurological disorders . She had already taken the CEO role by late 2020, when Huanyi Bio announced an angel round in the tens of millions of RMB backed by 5Y Capital and Xinyuan Capital . Her background bridges technology and biology: in a 2021 5Y Capital talk she described the company's work as engineering modeling of multi-omics immune data to accelerate biomarker and target identification .

elsewhere's corpus does not cover Wen Wen beyond her role at Huanyi Bio; the background articles mentioning her name are about other GenAI founders and products.